Evidence map›Paper›PMID 42125800›Full record

ArticleCirculation research2026

Conserved Transcriptional Circuits Regulate Cardiac Fibroblast-Mediated Fibrosis.

Crisdion Krstevski, Gabriella E Farrugia, Ian Hsu, Malathi S I Dona, Taylah L Gaynor, Charles D Cohen, Rebecca L Harper, Thomas I Harrison, Sebastien R Raffaut, Bethany Claridge and 8 more

Abstract read
In one paragraph

Article in Circulation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Crisdion KrstevskiCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0001-8408-7331
Gabriella E FarrugiaCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0002-9240-9027
Ian HsuCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0002-3462-7886
Malathi S I DonaCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0002-0337-4417
Taylah L GaynorCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.
Charles D CohenCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0002-4700-6368
Rebecca L HarperCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.
Thomas I HarrisonCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.
Sebastien R RaffautCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0009-0002-5400-1036
Bethany ClaridgeCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0002-4589-1033
Auriane DrackCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0003-4893-952X
Patrick LelliottCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0002-4666-1846
Aascha BrownPreclinical Cardiology, Microsurgery and Imaging Platform, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia (A.B., D.G.D.).ORCID 0000-0002-6931-3502
Julie R McMullenCardiac Hypertrophy (J.R.M.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0002-8316-1066
Daniel G DonnerBaker Department of Cardiometabolic Health, University of Melbourne, Parkville, Victoria, Australia (A.D., P.L., J.R.M., D.G.D., D.W.G., A.R.P.).ORCID 0000-0003-4924-720X
Sean LalSchool of Medical Sciences, Faculty of Medicine and Health (S.L.), University of Sydney.ORCID 0000-0002-5841-560X
David W GreeningCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0001-7516-485X
Alexander R PintoCardiac Cellular Systems (C.K., G.E.F., I.H., M.S.I.D., T.L.G., C.D.C., R.L.H., T.I.H., S.R.R., B.C., A.D., P.L., D.W.G., A.R.P.), Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0001-6421-4970

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac fibrosis is a major cause of cardiac dysfunction and is associated with virtually all forms of heart disease. Recently, single-cell genomic approaches have revealed in unprecedented resolution the orchestrated cellular responses driving cardiac fibrosis. Yet, the fibrosis-inducing phenotypes that emerge in the heart after nonischemic cardiac stress and the transcriptional circuits that govern fibrogenic cellular phenotypes are not well understood.

methodsApplying a single-cell paired-multiomic approach-by which both transcriptomic and epigenetic information is captured from individual cells-we reveal key transcription factors, in mouse and human hearts, associated with fibrosis development after nonischemic cardiac insults. Using high-throughput bulk transcriptomic and proteomic analyses, microscopy, and functional in vitro assays, we validate the distinct roles of new and established transcription factors in cardiac fibrosis.

resultsAnalysis of mouse hearts undergoing reverse remodeling after angiotensin II stimulation, where cardiac fibrosis dissipates, we find these factors are reversibly activated. Further, silencing transcription factors-including those we have identified that are previously unlinked to cardiac fibrosis, such as CREB3L2 (CAMP Responsive Element Binding Protein 3 Like 2), BNC2 (Basonuclin Zinc Finger Protein 2), and NFAT5 (Nuclear Factor of Activated T Cells 5)-modulates induction of extracellular matrix gene expression by human cardiac fibroblasts. Detailed analysis of CREB3L2 showed that it regulates cardiac fibrosis by modulating extracellular matrix synthesis through a dual mechanism-involving its N-terminal transactivation domain and a paracrine-acting C-terminal fragment-which is triggered after endoplasmic reticular stress.

conclusionsThis study identifies critical transcription factors regulating cardiac fibrosis and offers promising new targets to ameliorate the development of fibrosis in the context of stressors that cause cardiac dysfunction.

Indexed as

FibroblastsGene Regulatory NetworksMyocardiumTranscription, GeneticAnimalsCells, CulturedFibrosisHumansMaleMiceMice, Inbred C57BLTranscription FactorsTranscription Factorsangiotensin IIextracellular matrixfibroblastsfibrosistranscription factors

Identifiers

PMID42125800
PMCPMC13277728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.